大麻和肠道运动:系统性审查
Galaxie Story1, Carrie-Ellen Briere2, D Julian McClements1
1Department of Food Science, University of Massachusetts, Amherst, MA, United States.
Current developments in nutrition
|October 3, 2023
概括
大麻醇 (CBD) 显示出胃肠道疾病的潜力,具有关于肠道运动的有希望的临床前数据. 然而,需要更多的临床研究来确定其有效性和这些疾病的最佳剂量.
科学领域:
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
- 对于大麻素的研究.
背景情况:
- Cannabidiol (CBD) 是一种无毒性大麻素,声称具有药用益处.
- 目前证据证明CBD对胃肠道 (GI) 疾病的疗效是有限的.
- 由于可用性和接受性,消费者对CBD用于GI问题的使用正在增加.
研究的目的:
- 系统地审查关于CBD,肠道运动性和相关疾病的现有研究.
- 评估当前关于CBD对胃肠道系统影响的知识边界.
- 评估CBD在功能性胃肠道疾病中的治疗潜力.
主要方法:
- 对已发表的研究进行系统的文献审查.
- 对CBD和肠道运动性的体外和临床前研究的评估.
- 分析可用的临床试验数据关于CBD治疗胃肠道运动障碍.
主要成果:
- 临床前数据表明,CBD可能对肠道运动有积极的影响,包括在大肠炎模型中.
- 在其他治疗领域,CBD已经证明了安全性和有效性,例如发作障碍和恶心/吐.
- 研究CBD对肠道运动障碍的临床试验有限,尚未显示出确的益处.
结论:
- 根据体外和临床前发现,CBD对功能性胃肠道疾病有希望.
- 研究设计存在显著的变化,包括CBD剂量和提取物成分.
- 需要进一步进行严格的临床试验,以确定CBD的疗效,最佳剂量以及对肠道运动障碍的具体应用.
相关概念视频
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
230
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
230
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
367
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
367
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
289
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
289
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
237
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
237
Drugs Affecting GI Tract Motility: Other Laxatives
256
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
256
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
300
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
300


